06 Jun, 2019 09:59 AM
SYDNEY, June 6, 2019: Noxopharm Ltd (ASX: NOX) (Noxopharm or ‘Company’) is pleased to provide the market with its updated corporate presentation for June 2019.
For further inf...read more
02 May, 2019 09:45 AM
Long-lasting responses with Veyonda + low-dose radiotherapy in late-stage prostate cancer
High proportion of disease control following a single, short course of treatment
Complete resolution ...read more
16 Apr, 2019 10:05 AM
New class of immuno-oncology drug identified
Activator of NK cells and CD4+ immune cells
Potential to boost function of current immuno-oncology drugs.
SYDNEY, April 16, 2019: Noxopharm (AS...read more
08 Apr, 2019 10:18 AM
OpenDNA partners with Novatti for Alipay and Wechat Pay processing
New channel for retail, education and tourism payments for Chinese consumers
B2B partnerships continue to grow...read more